| Structure |
Chemical Name |
CAS |
MF |
![Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)-](/CAS/20200515/GIF/66722-65-4.gif) |
Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)- |
66722-65-4 |
C20H33NO5 |
 |
Pyrimidine, 4-bromo-6-(1-bromoethyl)-5-fluoro- |
1307315-02-1 |
C6H5Br2FN2 |
 |
4-(3,4-dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine oxide |
209473-00-7 |
C17H15Cl2NO |
 |
Tazobactam Impurity EBT |
|
|
|
|
Mixture of Cefoxitin Impurities E&F |
|
|
|
|
Faropenem Degradation Impurity 4 |
|
|
|
|
7-(2-hydroxy-1,1-dimethoxypropyl)-5H-chromeno[2,3-b]pyridin-5-ol |
|
|
|
|
2-chloro-1-(5-methoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
 |
Oxacillin Impurity 3 |
21106-64-9 |
C19H18ClN3O5S |
 |
Latanoprost Impurity 3 |
2278245-92-2 |
C27H41BrO5 |
 |
Ethyl 2-(2-Iodoethoxy)acetate |
56703-25-4 |
C6H11IO3 |
|
|
Butyphthalide impurity 53 |
|
|
 |
6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE |
21237-84-3 |
C14H16Br2N2O |
 |
DESTHIAZOLYLMETHYL RITONAVIR |
256328-82-2 |
C33H43N5O4S |
 |
S-DIDEMETHYL CITALOPRAM |
166037-78-1 |
C18H17FN2O |
 |
METHOTREXATE DIMETHYL ESTER |
34378-65-9 |
C22H26N8O5 |
|
|
Sugammadex sodium Org199129-1 Impurity |
|
|
|
|
Sugammadex sodium Impurity 41 |
|
|
![CLOPIDOGREL RELATED COMPOUND C (20 MG) (METHYL (-)-(R)-(O-CHLOROPHENYL)-6,7-DIHYDROTHIE-NO[3,2-C]PYRIDINE-5(4H)-ACETATE, HYDROGEN SUL- FATE)](/CAS/GIF/120202-71-3.gif) |
CLOPIDOGREL RELATED COMPOUND C (20 MG) (METHYL (-)-(R)-(O-CHLOROPHENYL)-6,7-DIHYDROTHIE-NO[3,2-C]PYRIDINE-5(4H)-ACETATE, HYDROGEN SUL- FATE) |
120202-71-3 |
C16H18ClNO6S2 |
 |
TERBUTALINE IMPURITY C |
139508-58-0 |
C12H17NO3 |
 |
3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOLE-2-CARBALDEHYDE |
101125-34-2 |
C18H16FNO |
 |
3,4-DIMETHOXY-2-HYDROXYBENZALDEHYDE |
19283-70-6 |
C9H10O4 |
 |
Apixaban Impurity 51 |
1620494-29-2 |
C33H32N4O5 |
 |
4-(5-methyl-2-phenyloxazol-4-yl)benzenesulfonamide |
2242749-01-3 |
C16H14N2O3S |
|
|
Cefazolin Impurity EP-I |
|
|
|
|
Cabozantinib impurity 42 |
|
|
|
|
Cabozantinib impurity 55 |
|
|
|
|
Canagliflozin Impurity 68 |
|
|
|
|
Dapoxetine impurity 51 |
|
|
|
|
Doxofylline Impurity 20 |
|
|
|
|
Dapoxetine impurity 64 |
|
|
|
|
Dapoxetine impurity 58 |
|
|
|
|
Brivaracetam Impurity 55 |
|
|
![alpha-(4-chlorophenyl)-alpha-[2-(dimethylamino)ethyl]pyridine-2-acetonitrile](/CAS/GIF/65676-21-3.gif) |
alpha-(4-chlorophenyl)-alpha-[2-(dimethylamino)ethyl]pyridine-2-acetonitrile |
65676-21-3 |
C17H18ClN3 |
|
|
Baloxavir Impurity ABCDEFGHJKL |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2514724-36-6 |
C22H19F2N3 |
 |
scopoline |
487-27-4 |
C8H13NO2 |
 |
N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide |
1474-02-8 |
C21H26N2O |
|
|
Oseltamivir Impurity 106 |
|
|
|
|
Oseltamivir Impurity 85 |
|
|
|
|
Oseltamivir Impurity 83 |
|
|
|
|
Oseltamivir Impurity 75 |
|
|
![[1,1'-bicyclohexyl]-1-carboxylic acid](/CAS/GIF/60263-54-9.gif) |
[1,1'-bicyclohexyl]-1-carboxylic acid |
60263-54-9 |
C13H22O2 |
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-](/CAS/20210305/GIF/2626934-45-8.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- |
2626934-45-8 |
C25H30Cl2N6OS2 |
|
|
Dapagliflozin Impurity 49 |
|
|
![11-[3-(dimethylamino)propyl]-6,11-dihydrodibenz[b,e]oxepin-11-ol](/CAS/GIF/4504-88-5.gif) |
11-[3-(dimethylamino)propyl]-6,11-dihydrodibenz[b,e]oxepin-11-ol |
4504-88-5 |
C19H23NO2 |
|
|
Avatrombopag Impurity ABCDEFGHJKL |
|
|
 |
1-(2-chloroethyl)-3-(dicyclopropylmethyl)urea |
54187-03-0 |
C10H17ClN2O |
![1,3-Dioxane-4-acetic acid, 6-[2-[3-[[[2-[(4R,6R)-6-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]amino]carbonyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-4-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)-](/CAS/20210305/GIF/1229658-18-7.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[3-[[[2-[(4R,6R)-6-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]amino]carbonyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-4-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)- |
1229658-18-7 |
C48H67FN2O9 |
![1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)-](/CAS/20210305/GIF/2588261-38-3.gif) |
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)- |
2588261-38-3 |
C37H43FN2O5 |
 |
3-hydroxy-2,4-dimethoxybenzaldehyde |
32246-34-7 |
C9H10O4 |
 |
butyl 3-aminosulphonyl-5-butylamino-4-phenoxybenzoate |
32643-00-8 |
C21H28N2O5S |
 |
11beta,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione |
1171-81-9 |
C21H30O6 |
 |
trans-2-amino-N-(4-hydroxycyclohexyl)benzamide |
15942-11-7 |
C13H18N2O2 |
 |
4-PYRIDIN-4-YL-BUTYRIC ACID |
102878-73-9 |
C9H11NO2 |
 |
4-O-(Carboxymethyl)rifamycin |
13929-35-6 |
C39H49NO14 |
 |
ethyl 3,5-bis(benzyloxy)benzoate |
50841-46-8 |
C23H22O4 |
 |
ethyl (R)-thiazolidine-4-carboxylate |
60664-15-5 |
C6H11NO2S |
![3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2504210-48-2.gif) |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
|
|
Faropenem Impurity D |
|
|
![[2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid](/CAS/GIF/24138-28-1.gif) |
[2S-(2alpha,5alpha,6alpha)]-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
24138-28-1 |
C8H10BrNO3S |
 |
5-nitro-2-furaldehyde (5-nitrofurfurylene)hydrazone |
736-53-8 |
C10H6N4O6 |
![4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride](/CAS/20211123/GIF/2454317-16-7.gif) |
4-(benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium chloride |
2454317-16-7 |
C38H41N4O4S |
 |
methyl (R)-thiazolidine-4-carboxylate |
42258-90-2 |
C5H9NO2S |
 |
Revefenacin Impurity 7 |
1158777-54-8 |
C14H19ClN2O3 |
|
|
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
|
|
Oxytocin Impurity 8 Trifluoroacetate |
|
|
|
|
Peramivir Dehydrated Impurity |
|
|
|
|
Apixaban Impurity 78 |
|
|
|
|
Formoterol Impurity 32 |
|
|
|
|
(1S,2S,3R,4R)-2-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-3-hydroxycyclopentane-1-carboxylic acid |
|
|
 |
Desloratadine EP impurity A hcl |
2250242-44-3 |
C19H21Cl2FN2 |
|
|
(R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one and (R)-6-(2-((R)-2,6-dimethyl- 5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
 |
(3S,4S)-Tofacitinib |
1092578-47-6 |
C16H20N6O |
|
|
Rosuvastatin Impurity 145 |
|
|
|
|
Apixaban Impurities 15 Complete Set |
|
|
|
|
Bumetanide Impurity 23 |
|
|
|
|
Rocuronium Bromide Impurity 34、35、36 |
|
|
 |
Vinpocetine impurity C |
70155-05-4 |
C23H28N2O3 |
|
|
Cloxacillin Impurity X |
|
|
|
|
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxamide |
|
|
|
|
Azilsartan Impurity 107 |
|
|
|
|
Perospirone Impurity 25 |
|
|
|
|
Paxlovid Impurity 16 |
|
|
|
|
3-(2-(cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
|
|
Fondaparinux sodium impurity 17 |
|
|
|
|
Fondaparinux sodium impurity 12 |
|
|
|
|
Piperacillin impurity L |
|
|
|
|
Piperacillin Impurity X |
|
|
 |
ETHYLTRITYLETHER |
968-39-8 |
C21H20O |
|
|
Bosutinib Impurity 41 |
|
|
 |
(S)-3-Dimethylamino-3-phenylpropanol |
82769-75-3 |
C11H17NO |
|
|
Valdecoxib N-Oxide |
|
|
|
|
Olodaterol Impurity 23 |
|
|
|
|
Miglitol Isomer impurities C |
|
|
|
|
Alpha-D-Methylglucoside |
|
|
 |
4-Desacetyl Vincristine |
3704-01-6 |
C44H54N4O9 |
|
|
Relugolix Impurity 91 |
|
|
 |
D,L N-Desmethylvenlafaxine |
149289-30-5 |
C16H25NO2 |
 |
PIVALOYLOXYMETHYL 6-AMINOPENICILANATE |
25031-08-7 |
C14H22N2O5S |